Influence of Fcγ RIIA and MBL polymorphisms on severe acute respiratory syndrome

Tissue Antigens

Volumn 66, Issue 4, 2005, Pages 291-296

  Yuan, Fang F ^a,e   Tanner, J ^a   Chan, P K S ^b,d   Biffin, S ^a   Dyer, W B ^a,c   Geczy, A F ^a,c   Tang, J W ^b   Hui, D S C ^b   Sung, J J Y ^b   Sullivan, J S ^a,c  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c University of Sydney   (Australia)

^d and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^e ARCBS Endeavour   (Australia)

Author keywords

Fc RIIA; MBL; Polymorphisms; SARS

Indexed keywords

DNA; FC RECEPTOR; FC RECEPTOR IIA; MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG; FC GAMMA RECEPTOR IIA; LEUKOCYTE ANTIGEN;

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FC GAMMA RIIA GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HOMOZYGOSITY; HONG KONG; HUMAN; INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MBL GENE; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; ALLELE; CASE CONTROL STUDY; GENETICS; IMMUNOLOGY; MIDDLE AGED; MORTALITY;

CORONAVIRUS; SARS COV;

ADULT; AGED; ALLELES; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, IGG; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 26044438261     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00476.x     Document Type: Article

References (20)

1. Chan-Yeung M. Severe acute respiratory syndrome (SARS) and Healthcare workers. Int J Occup Environ Health 2004: 10: 421-7.
2. Chan JWM, Ng CK, Chan YH et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003: 58: 686-9.
3. Liu XQ, Chen SB, He GQ, et al. Management of critical severe acute respiratory syndrome and risk factors for death. Zhonghua Jie He He Hu Xi Za Zhi 2003: 26: 329-33.
4. Platonov AE, Shipulin GA, Vershinina IV, Dankert J, van de Winkel JGJ, Kuijper EJ. Association of human FcγRIIA (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis 1998: 27: 746-50.
5. Yuan FF, Wong M, Pererva N et al. FcγRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 2003: 81: 192-5.
6. Loke H, Bethell D, Phuong CXT et al. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc receptor IIA genes. Am J Trop Med Hyg 2002: 67: 102-6.
7. Brouwer KC, Lal RB, Mirel LB et al. Polymorphism of Fc receptor lia for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS 2004: 18: 1187-94.
8. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000: 68: 688-93.
9. Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998: 199: 327-39.
10. Van Dorge NM, van der Pol WL, van de Winker JGJ. Fcγ R polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003: 61: 189-202.
11. Horiuchi T, Gondo H, Miyagawa H et al. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun 2005: 6: 162-6.
12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
13. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the relationship between monnose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002: 56: 630-41.
14. Mullighan CG, Heatley S, Doherty K et al. Monnose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002: 99: 3524-9.
15. Wong VW, Dai D, Wu AK, Sung JJ. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003: 9: 119-201.
16. Skowronski DM, Astell C, Brunham RC et al. Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 2005: 56: 357-81.
17. Tan YJ, Goh PY, Fielding BC et al. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol 2004: 11: 362-71.
18. Traggiai E, Becker S, Subbarao K et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS cornonavirus. Nat Med 2004: 10: 871-5.
19. Van der Pol WL, van de Winkel JGJ. IgG receptor polymorphisms: risk factor for disease. Immunogenetics 1998: 48: 222-32.
20. Ip WKE, Chan KH, Law HKW et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. Jinfect Dis 2005: 191: 1697-704.